BioCentury
ARTICLE | Company News

BioForm, Merz deal

January 25, 2010 8:00 AM UTC

Merz began its previously announced tender offer to acquire all outstanding shares of BioForm for $5.45 per share. The tender offer expires at midnight on Feb. 12 (see BioCentury, Jan. 11). ...